Related Experiment Video
Updated: Jun 27, 2026

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
Diagnosis of macroamylasemia in a pregnant patient
Adrienne J Headley1, Andrew N Blechman
1Department of Obstetrics and Gynecology, Jersey Shore University Medical Center, Neptune, NJ 07743, USA.
Background:
Macroamylasemia occurs with the formation of macroamylase complexes that cannot be cleared via renal excretion. In patients with persistent serum amylase elevation or hyperamylasemia with normal urine amylase and lipase levels, the diagnosis of macromylasemia is suggested.
Main Findings:
The patient is a 31-year-old G2P1 who presented to the ob/gyn triage with the complaint of recurrent right-sided abdominal pain. Serum amylase values were elevated. The patient had been admitted previously at GA 16 weeks for recurrent acute cholecystitis and gallstone pancreatitis and had undergone laparoscopic cholecystectomy.
Conclusion:
In the absence of characteristic findings suggestive of acute cholecystitis or gallstone pancreatitis, clinicians should evaluate urinary and serum amylase isoenzymes to exclude hyperamylasemia due to elevated serum macroamylase levels. Additional interventions may not be required to assure optimal maternal or fetal outcome.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Inborn Errors of Metabolism
Hyperglycemia
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

